DOTA-BIM-23014:DOTA-Lanreotide
DOTA-BIM-23014:DOTA-Lanreotide Basic information
- Product Name:
- DOTA-BIM-23014:DOTA-Lanreotide
- Synonyms:
-
- DOTA-BIM-23014:DOTA-Lanreotide
- L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 → 7) disulfide
- DOTA-Lanreotide
- DOTA-Lanreotide acetate
- L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-Lcysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-Lcysteinyl-,cyclic (2)-disulfide
- L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide
- CAS:
- 213187-44-1
- MF:
- C70H95N15O17S2
- MW:
- 1482.72
- Mol File:
- 213187-44-1.mol
More
Less
DOTA-BIM-23014:DOTA-Lanreotide Chemical Properties
- Boiling point:
- 1750.5±65.0 °C(Predicted)
- Density
- 1.45±0.1 g/cm3(Predicted)
- pka
- 1.83±0.10(Predicted)
- Sequence
- {DOTA}-{d-2Nal}-Cys-Tyr-{d-Trp}-Lys-Val-Cys-Thr (disulfide bridge:Cys2-Cys7)
More
Less
DOTA-BIM-23014:DOTA-Lanreotide Usage And Synthesis
Chemical Properties
Colourless to off-white lyophilised powder
Uses
DOTA-Lanreotide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].